Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study

Dec-20

Cardiovascular Gastroenterology Pharmacoepidemiology

AUTHORS : Dr Wallis C. Y. Lau, Research Department of Practice and Policy, School of Pharmacy, University College London, Mezzanine Floor, British Medical Association House, Entrance A, Tavistock Square, London WC1H 9JP, UK – Email: wallis.lau@ucl.ac.uk – Profile: https://iris.ucl.ac.uk/iris/browse/profile?upi=CYLAU57

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 29(12):1550-1561

DOI : 10.1002/pds.5130

Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study